📋 GSK’s Exdensur Approved In Japan For Severe Asthma And CRSwNP 완벽가이드
✨ GSK’s Exdensur Approved In Japan For Severe Asthma And CRSwNP
★ 56 전문 정보 ★
(RTTNews) – GSK plc (GSK, GSK.L) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Exdensur (depemokimab) for the treatment of bronchial asthma (limited to severe or refractory patients whose symptoms cannot be controlled with existing therap
🎯 핵심 특징
✅ 고품질
검증된 정보만 제공
⚡ 빠른 업데이트
실시간 최신 정보
💎 상세 분석
전문가 수준 리뷰
📖 상세 정보
(RTTNews) – GSK plc (GSK, GSK.L) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Exdensur (depemokimab) for the treatment of bronchial asthma (limited to severe or refractory patients whose symptoms cannot be controlled with existing therap